Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Comment
  • Published:

Not a spectator sport: improving participation of Black patients in cardiovascular clinical trials

Nature Reviews Cardiology volume 21, pages 67–68 (2024)Cite this article

Subjects

Representation of Black patients in cardiovascular clinical trials remains dismally low, reflective of systemic and structural barriers, which can lead to missed opportunities to meet community-identified needs, understand responses to medical therapies and improve cardiovascular care. Innovative, multilevel strategies focused on Black communities are warranted to increase enrolment of this population into clinical research.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. Kyalwazi, A. N. et al. Disparities in cardiovascular mortality between Black and White adults in the United States, 1999 to 2019. Circulation 146, 211–228 (2022).

    Article  PubMed  PubMed Central  Google Scholar 

  2. LaVeist, T. A. et al. The economic burden of racial, ethnic, and educational health inequities in the US. J. Am. Med. Assoc. 329, 1682–1692 (2023).

    Article  Google Scholar 

  3. Prasanna, A. et al. Recruitment of Black adults into cardiovascular disease trials. J. Am. Heart Assoc. 10, e021108 (2021).

    Article  PubMed  PubMed Central  Google Scholar 

  4. Tossas, K. Y. et al. Advocating for a “community to bench model” in the 21st century. EBioMedicine 53, 102688 (2020).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Reopell, L. et al. Community engagement and clinical trial diversity: navigating barriers and co-designing solutions — a report from the “Health Equity through Diversity” seminar series. PLoS ONE 18, e0281940 (2023).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Gray, D. M. II, Nolan, T. S., Gregory, J. & Joseph, J. J. Diversity in clinical trials: an opportunity and imperative for community engagement. Lancet Gastroenterol. Hepatol. 6, 605–607 (2021).

    Article  PubMed  Google Scholar 

  7. Dhaliwal, R. et al. Eradicating racism: an Endocrine Society policy perspective. J. Clin. Endocrinol. Metab. 107, 1205–1215 (2022).

    Article  PubMed  Google Scholar 

  8. Gray Ii, D. M., Nolan, T. S., Bignall, O. N. R. II, Gregory, J. & Joseph, J. J. Reckoning with our trustworthiness, leveraging community engagement. Popul. Health Manag. 25, 6–7 (2022).

    Article  PubMed  Google Scholar 

  9. Haynes, N., Kaur, A., Swain, J., Joseph, J. J. & Brewer, L. C. Community-based participatory research to improve cardiovascular health among US racial and ethnic minority groups. Curr. Epidemiol. Rep. 9, 212–221 (2022).

    Article  PubMed  PubMed Central  Google Scholar 

  10. National Institutes of Health. Community Partnerships to Advance Science for Society (ComPASS). https://commonfund.nih.gov/compass (2023).

Download references

Acknowledgements

The authors are grateful to Mathias Lalika (Mayo Clinic, USA) for his editorial assistance and assistance with the preparation of Box 1. L.C.B. was supported by the AHA Second Century Implementation Science award (grant 23SCISA1144689), the Robert A. Winn Career Development award (Bristol Myers Squibb Foundation), the NIH and the National Institute on Minority Health and Health Disparities (grant P50MD017342), and the clinical and translational science awards (grant UL1 TR000135) from the National Center for Advancing Translational Sciences (NCATS) to the Mayo Clinic. J.J.J. was supported by the AHA Strategically Focused Research Network award (23SFRNCCS1052486), an NIH grant (R01DK132403), an Agency for Healthcare Research and Quality grant (R01HS028822), and the clinical and translational science awards (UM1TR004548) from NCATS to The Ohio State University. The contents of this article are solely the responsibility of the authors and do not necessarily represent the official views of NCATS or NIH. The funding bodies had no role in the writing of the manuscript, nor in the decision to submit the manuscript for publication.

Author information

Authors and Affiliations

  1. Division of Preventive Cardiology, Department of Cardiovascular Medicine, Mayo Clinic, Rochester, MN, USA

    LaPrincess C. Brewer

  2. Division of Endocrinology, Department of Medicine, The Ohio State University Wexner Medical Center, Columbus, OH, USA

    Joshua J. Joseph

Authors
  1. LaPrincess C. Brewer
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Joshua J. Joseph
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to LaPrincess C. Brewer.

Ethics declarations

Competing interests

The authors declare no competing interests.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Brewer, L.C., Joseph, J.J. Not a spectator sport: improving participation of Black patients in cardiovascular clinical trials. Nat Rev Cardiol 21, 67–68 (2024). https://doi.org/10.1038/s41569-023-00978-9

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41569-023-00978-9

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing